---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-005267"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2024-02-07T23:59:59+00:00"
generated_at: "2026-06-06T07:07:18.064048+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# INBS raises $1.77M via Series E warrant exercise; issues Series G warrants at $4.50

## Summary
- Existing warrant holders exercised 606,064 shares at $2.9232 for gross proceeds of ~$1.77M.
- Holders receive one Series G warrant per exercised warrant, exercisable at $4.50 for 5.5 years.
- Company to use net proceeds for working capital and general corporate purposes.
- Ladenburg Thalmann acted as placement agent; fees include 8% cash fee and 5% warrant coverage.
- Resale registration statement for Series G shares must be filed within 30 days.

## SEC filing metadata
- accession: 0001493152-24-005267
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2024-02-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315224005267/0001493152-24-005267-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315224005267/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-005267
- JSON: https://secwatch.observer/filing/0001493152-24-005267.json
- Plain text: https://secwatch.observer/filing/0001493152-24-005267.txt

## Key facts
- Material Agreements
  INTELLIGENT BIO SOLUTIONS INC. entered into Agreements with certain accredited and institutional holders valued at approximately $1.77 million (effective 2024-02-04).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain accredited and institutional holders
  - Value: approximately $1.77 million
  - Effective: 2024-02-04
  source text: On February 4, 2024, Intelligent Bio Solutions Inc. (the “Company”) entered into warrant inducement agreements (the “Agreements”) with certain accredited and institutional holders (collectively, the “Holders”) of the Company’s outstanding Series E Warrants issued on October 4, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1725430/000149315224005267/0001493152-24-005267-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.